Transmedics Group Inc at Morgan Stanley Healthcare Conference Transcript
Let's get going here as we kind of wrap up our first day at the health care conference. My name is David Lewis, medical device analyst here at Morgan Stanley. It's my pleasure to have with us here several members of -- 2 members of the TransMedics management team, Waleed Hassanein and Stephen Gordon, CEO and CFO, respectively.
Questions & Answers
We're going to jump straight into Q&A. But I thought, Waleed, just given some of the recent IPO, it'd be kind of helpful just to help people frame sort of the broader opportunity for the business. Maybe just quickly tell us or capsulate, what is the problem with today's organ transplantation, sort of what is the problem that OCS is trying to solve?
Sure. First, thank you, David, for inviting us to the conference. At a high level, I mean, we're very excited about
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |